JN.1

The new booster, available since September, is effective against the currently dominant SARS-CoV-2 variant in the U.S., JN.1.
The Wall Street Journal published a news article on January 5, “Why It Feels Like Everyone You Know Is Getting COVID-19,” which contained several worrisome observations.